Back to Search
CHELSEY WILLETT, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1871931683Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
PMID 14745444·Nat Med·2004
3-trial
Update on combined-modality treatment options for pancreatic cancer.
PMID 14723004·Oncology (Williston Park)·2003
6-review
Proline biosynthesis genes and their regulation under salinity stress in the euryhaline copepod Tigriopus californicus.
PMID 12128060·Comp Biochem Physiol B Biochem Mol Biol·2002
7-preclinical
Viability of cytochrome c genotypes depends on cytoplasmic backgrounds in Tigriopus californicus.
PMID 11580018·Evolution·2001
7-preclinical
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
PMID 19117696·Int J Radiat Oncol Biol Phys·2009
6-review
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.
PMID 19470921·J Clin Oncol·2009
3-trial
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
PMID 18805651·Int J Radiat Oncol Biol Phys·2009
8-other
Chemoradiotherapy in gastrointestinal malignancies.
PMID 19577442·Clin Oncol (R Coll Radiol)·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
Via practice · 2 locations total
- Address
- 410 PELZER HWY
EASLEY, SC 29642 - Phone
- (864) 855-6856
Quick Facts
- NPI
- 1871931683
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile